AlphaQuest LLC reduced its holdings in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC – Free Report) by 52.2% in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 6,315 shares of the company’s stock after selling 6,895 shares during the quarter. AlphaQuest LLC’s holdings in GE HealthCare Technologies were worth $474,000 as of its most recent SEC filing.
A number of other institutional investors have also made changes to their positions in GEHC. Dodge & Cox boosted its position in GE HealthCare Technologies by 42.1% during the second quarter. Dodge & Cox now owns 23,567,950 shares of the company’s stock worth $1,745,678,000 after purchasing an additional 6,982,441 shares during the period. Norges Bank bought a new stake in shares of GE HealthCare Technologies during the 2nd quarter worth about $468,120,000. Holocene Advisors LP grew its stake in GE HealthCare Technologies by 178.5% in the 2nd quarter. Holocene Advisors LP now owns 4,027,352 shares of the company’s stock valued at $298,306,000 after buying an additional 2,581,522 shares during the last quarter. Menora Mivtachim Holdings LTD. acquired a new position in GE HealthCare Technologies in the 2nd quarter valued at about $80,755,000. Finally, Balyasny Asset Management L.P. bought a new position in GE HealthCare Technologies in the 2nd quarter valued at about $58,388,000. 82.06% of the stock is owned by institutional investors and hedge funds.
Analysts Set New Price Targets
A number of brokerages have recently weighed in on GEHC. Stifel Nicolaus increased their target price on GE HealthCare Technologies from $95.00 to $98.00 and gave the stock a “buy” rating in a research note on Wednesday. Jefferies Financial Group lifted their target price on GE HealthCare Technologies from $95.00 to $105.00 and gave the stock a “buy” rating in a report on Thursday, December 11th. Bank of America boosted their target price on shares of GE HealthCare Technologies from $82.00 to $92.00 and gave the company a “neutral” rating in a research report on Monday, January 5th. Wells Fargo & Company raised their price target on shares of GE HealthCare Technologies from $95.00 to $97.00 and gave the stock an “overweight” rating in a research report on Thursday. Finally, Morgan Stanley boosted their price objective on shares of GE HealthCare Technologies from $80.00 to $85.00 and gave the company an “equal weight” rating in a report on Wednesday. Seven research analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average price target of $92.42.
GE HealthCare Technologies Stock Down 0.4%
NASDAQ GEHC opened at $82.31 on Friday. The business has a fifty day moving average price of $82.72 and a two-hundred day moving average price of $77.50. The stock has a market capitalization of $37.49 billion, a PE ratio of 18.05, a PEG ratio of 2.46 and a beta of 1.08. GE HealthCare Technologies Inc. has a fifty-two week low of $57.65 and a fifty-two week high of $94.80. The company has a debt-to-equity ratio of 0.91, a current ratio of 1.37 and a quick ratio of 0.95.
GE HealthCare Technologies (NASDAQ:GEHC – Get Free Report) last posted its quarterly earnings results on Wednesday, February 4th. The company reported $1.44 EPS for the quarter, topping analysts’ consensus estimates of $1.40 by $0.04. The company had revenue of $5.70 billion during the quarter, compared to analysts’ expectations of $5.60 billion. GE HealthCare Technologies had a return on equity of 21.35% and a net margin of 10.11%.GE HealthCare Technologies’s revenue was up 7.1% on a year-over-year basis. During the same quarter in the previous year, the firm earned $1.45 EPS. GE HealthCare Technologies has set its FY 2026 guidance at 4.950-5.150 EPS. Equities analysts expect that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current fiscal year.
GE HealthCare Technologies Announces Dividend
The business also recently declared a quarterly dividend, which will be paid on Friday, February 13th. Stockholders of record on Friday, January 9th will be paid a $0.035 dividend. This represents a $0.14 dividend on an annualized basis and a dividend yield of 0.2%. The ex-dividend date is Friday, January 9th. GE HealthCare Technologies’s dividend payout ratio (DPR) is presently 2.89%.
Key GE HealthCare Technologies News
Here are the key news stories impacting GE HealthCare Technologies this week:
- Positive Sentiment: Q4 results and outlook beat — GEHC reported $1.44 EPS (vs. $1.40 est.) and $5.7B revenue (vs. $5.6B est.), and raised FY‑2026 EPS guidance to $4.95–5.15 (above consensus), a key driver of recent optimism. GE HealthCare reports fourth quarter and full year 2025 financial results
- Positive Sentiment: Evercore ISI raised its price target to $98 with an “outperform” rating ( ~19% upside from current levels), signalling continued analyst confidence after the quarter. Benzinga
- Positive Sentiment: Wells Fargo boosted its PT to $97 and kept an “overweight” rating, citing the stronger results/guidance as support for higher estimates. Benzinga
- Positive Sentiment: BTIG raised its price target to $91 and maintained a “buy” call, another vote of confidence from the sell side after the quarter. GE HealthCare (GEHC) PT Raised to $91 at BTIG
- Neutral Sentiment: Market commentary is bullish on further upside — pieces noting the post‑earnings “pop” argue room remains to run, but they largely reflect sentiment rather than new fundamentals. GE HealthCare Technologies Pops, And The Upside Isn’t Over Yet
- Negative Sentiment: Margin pressure noted — several reports highlight a slide in net margin driven by tariffs and product mix, which tempers the EPS beat and could limit multiple expansion. GE HealthCare Q4 Earnings and Revenues Beat Estimates, Net Margin Falls
- Negative Sentiment: Coverage notes profit fell despite higher revenue — the WSJ and others emphasize the profitability hit, a reminder that growth is not yet fully translating into margin expansion. GE HealthCare Technologies Posts Lower Profit, Despite Higher Revenue
About GE HealthCare Technologies
GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.
In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.
See Also
- Five stocks we like better than GE HealthCare Technologies
- “Fed Proof” Your Bank Account with THESE 4 Simple Steps
- When to buy gold (mathematically)
- NEW LAW: Congress Approves Setup For Digital Dollar?
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
- GOLD ALERT
Want to see what other hedge funds are holding GEHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for GE HealthCare Technologies Inc. (NASDAQ:GEHC – Free Report).
Receive News & Ratings for GE HealthCare Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GE HealthCare Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
